Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
Molecules · 2023
DOI: 10.3390/molecules28093861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Samuele Ciceri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Milan, Via L. Mangiagalli 25, 20133 Milano, Italy. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Endometriosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its presence on the market since 2018, a thorough NMR analysis of this drug, together with its synthetic intermediates, is still lacking. Hence, with the aim of filling this literature gap, we here performed a detailed NMR investigation, which allowed the complete assignment of the 1H, 13C, and 15N NMR signals. These data allowed, with the support of the conformational analysis, the determination of the stereochemical profile of the two atropisomers, detectable in solution. Moreover, these latter were also detected by means of cellulose-based chiral HPLC, starting from a sample prepared through an implemented synthetic procedure with respect to the reported ones. Overall, these results contribute to further understanding of the topic of atropisomerism in drug discovery and could be applied in the design of safe and stable analogs, endowed with improved target selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Milan, Via L. Mangiagalli 25, 20133 Milano, Italy.
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Via C. Saldini 50, 20133 Milano, Italy.
- Chemical-Pharmaceutical Consulting and IP Management, Viale G. da Cermenate 58, 20141 Milano, Italy.
- Tecnomed Foundation, University of Milano-Bicocca, Via Pergolesi 33, 20900 Monza, Italy.
- Department of Chemistry, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
ORCID-Profile: Samuele Ciceri, Diego Colombo, Enrico M A Fassi, Patrizia Ferraboschi, Giovanni Grazioso, Marco Iannone, Carlo Castellano, Fiorella Meneghetti
Zitieren
APA
Ciceri, S., Colombo, D., Fassi, E. M. A., Ferraboschi, P., Grazioso, G., Grisenti, P., Iannone, M., Castellano, C., & Meneghetti, F. (2023). Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study. Molecules. https://doi.org/10.3390/molecules28093861
Vancouver
Ciceri S, Colombo D, Fassi EMA, Ferraboschi P, Grazioso G, Grisenti P, et al. Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study. Molecules. 2023. doi:10.3390/molecules28093861
BibTeX
@article{Ciceri2023,
author = {Ciceri, Samuele and Colombo, Diego and Fassi, Enrico M A and Ferraboschi, Patrizia and Grazioso, Giovanni and Grisenti, Paride and Iannone, Marco and Castellano, Carlo and Meneghetti, Fiorella},
title = {Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093861}
}
EUVIMED